Granulocyte colony-stimulating factor (G-CSF) dose-dependent efficacy in peripheral blood stem cell mobilization in patients who had failed initial mobilization with chemotherapy and G-CSF

Bone Marrow Transplantation

Volumn 22, Issue 9, 1998, Pages 853-857

  Lie, A K W ^a   Hui, C H ^a   Rawling, T ^a   Dyson, P G ^a   Thorp, D ^a   Benic, J ^a   Rawling, C M ^a   Toogood, I ^b   Horvath, N ^a   Simmons, P J ^a   To, L B ^a  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

CD34; CFU GM; Chemotherapy; G CSF; Stem cell mobilization

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; METHYLPREDNISOLONE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; APHERESIS; ARTICLE; CANCER CHEMOTHERAPY; CELL TRANSPLANTATION; CHILD; CLINICAL ARTICLE; COLONY FORMING UNIT GM; DOSE RESPONSE; FEMALE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MALE; MONONUCLEAR CELL; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031740031     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701463     Document Type: Article

References (21)

1. Richman CM, Weiner RS, Yankee RA. Increase in circulating stem cells following chemotherapy in man. Blood 1976; 47: 1031-1039.
2. To LB, Shepperd M, Haylock DN et al. Single high doses of cyclophosphamide enables the collection of high numbers of haemopoictic stem cells from the peripheral blood. Exp Hematol 1990; 18: 442-447.
3. 2 in patients with advanced cancer. ANZ J Med 1992; 22: 660-664.
4. Schwartzberg LS, Birch R, Hazelton B et al. Peripheral blood stem cell mobilisation by chemotherapy with and without recombinant human granulocytc colony-stimulating factor. J Hematother 1992; 1: 317-327.
5. Kotusek D, Shepherd KM, Sage RE et al. Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in lymphoma. myeloma and solid tumours. Bone Marrow Transplant 1992; 9: 11-17.
6. Gianni AM, Bregni M, Siena S et al. Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of highdose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma. J Clin Oncol 1990: 8: 768-778.
7. Brugger W, Bross K, Frisch J et al. Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide and cisplatin. Blood 1992; 79: 1193-1200.
8. Elias AD, Ayash L, Anderson KC et al. Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification tor breast cancer. Blood 1992; 79: 3036-3044.
9. Sheridan WP, Begley CG, Juttner CA et al Effect of peripheral blood progenitor cells mobilized by rilgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1992; 339: 640-644.
10. Lie AKW, Rawling TP, Bayly JL, To LB. Progenitor cell yield in sequential blood stem cell mobilization in the same patients: insights into chemotherapy dose escalation and combination of hematopoietic growth factor and chemotherapy. Br J Haematol 1996; 95: 39-44.
11. Waller CF, Bertz H, Wenger MK et al. Mobilization of peripheral blood progenitor cells for allogeneic transplantation: efficacy and toxicity of a high-dose rhG-CSF regimen. Bone Marrow Transplant 1996; 18: 279-283.
12. Duhrsen U, Villeval J-L, Boyd J et al. Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood 1988; 72: 2074-2081.
13. Matsunaga T, Sakamaki S, Kongo Y et al. Recombinant human granulocyte colony-stimulating factor can mobilize sufficient amounts of peripheral blood stem cells in healthy volunteer for allogeneic transplantation. Bone Marrow Transplant 1993; 11: 103-108.
14. Teshima T, Harada M, Takamatsu Y et al Cytotoxic drug and cytotoxic drug/G-CSF mobilization of peripheral blood stem cells and their use for autogmfting. Bone Marrow Transplant 1992; 10: 215-220.
15. Pettengell R, Testa NG, Swindell R et al. Transplantation potential of hematopoietic colls released into ihe circulation during routine chemotherapy for non-Hodgkin's lymphoma. Blood 1993; 82: 2239-2248.
16. Lévesque JP, Leavesley DI, Niutta S et al. Cytokines increase human hematopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins. J Exp Med 1995; 181: 1805-1815.
17. Silver I, Murrils R, Etherington D. Microelectrode studies on the acid micro-environment beneath adherent macrophages and osteoclasts. Exp Cell Res 1988; 175: 266-276.
18. Takamatsu Y, Simmons PJ, Moore RJ et al. Oslcoelast-mediated bone resorption is stimulated during granulocyte colony-stimulating factor-induced haemopoietic progenitor cell mobilisation. Blood (in press).
19. Shepherd KM, Charles P, Sage RE et al. Mobilisation of haemopoietic stem cells by cyclophosphamide into peripheral blood of patients with haematological malignancies. Clin Lab Haematol 1991; 13: 25-32.
20. Haas R, Mohle R, Fruhauf S et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994; 83: 3787-3794.
21. Fruehauf S, Haas R, Conradt C et al. Peripheral blood progenitor cell (PBPC) counts during steady-state hematopoiesis allow to estimate the yield of mobilized PBPC after filgrastim (r-metHuG-CSF)-supported cytotoxic chemotherapy. Blood 1995; 85: 2619-2626.